News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
713,015 Results
Type
Article (43598)
Company Profile (467)
Press Release (668950)
Section
Business (211678)
Career Advice (2094)
Deals (36328)
Drug Delivery (96)
Drug Development (84002)
Employer Resources (173)
FDA (16473)
Job Trends (15241)
News (356981)
Policy (33485)
Tag
Academia (2689)
Alliances (51288)
Alzheimer's disease (1280)
Approvals (16395)
Artificial intelligence (141)
Bankruptcy (362)
Best Places to Work (11853)
Biotechnology (349)
Breast cancer (125)
Cancer (1124)
Cardiovascular disease (103)
Career advice (1752)
Cell therapy (251)
Clinical research (66549)
Collaboration (409)
Compensation (199)
COVID-19 (2612)
C-suite (102)
Data (1140)
Diabetes (160)
Diagnostics (6312)
Earnings (87442)
Employer resources (150)
Events (115000)
Executive appointments (320)
FDA (17021)
Funding (368)
Gene therapy (193)
GLP-1 (618)
Government (4480)
Healthcare (19245)
Infectious disease (2698)
Inflammatory bowel disease (115)
Interviews (319)
IPO (16722)
Job creations (3774)
Job search strategy (1502)
Layoffs (446)
Legal (8051)
Lung cancer (180)
Manufacturing (184)
Medical device (13537)
Medtech (13542)
Mergers & acquisitions (19671)
Metabolic disorders (432)
Neuroscience (1572)
NextGen Class of 2024 (6823)
Non-profit (4629)
Northern California (1500)
Obesity (249)
Opinion (204)
Patents (103)
People (58596)
Phase I (20801)
Phase II (29344)
Phase III (21752)
Pipeline (460)
Postmarket research (2668)
Preclinical (8953)
Radiopharmaceuticals (253)
Rare diseases (236)
Real estate (6126)
Regulatory (22281)
Research institute (2455)
Resumes & cover letters (360)
Southern California (1328)
Startups (3780)
United States (13960)
Vaccines (572)
Weight loss (188)
Date
Today (140)
Last 7 days (824)
Last 30 days (3927)
Last 365 days (36918)
2024 (33863)
2023 (41257)
2022 (52587)
2021 (57137)
2020 (55423)
2019 (48141)
2018 (36259)
2017 (33568)
2016 (33001)
2015 (39129)
2014 (32883)
2013 (27762)
2012 (29967)
2011 (30535)
2010 (28703)
Location
Africa (773)
Arizona (204)
Asia (39700)
Australia (6639)
California (3429)
Canada (1294)
China (254)
Colorado (148)
Connecticut (162)
Europe (87412)
Florida (462)
Georgia (116)
Illinois (357)
Indiana (200)
Kansas (99)
Maryland (596)
Massachusetts (2734)
Michigan (163)
Minnesota (280)
New Jersey (976)
New York (975)
North Carolina (783)
Northern California (1500)
Ohio (142)
Pennsylvania (852)
South America (1149)
Southern California (1328)
Texas (478)
Utah (92)
Washington State (375)
713,015 Results for "phage therapeutics international inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
BiomX Announces Entry into Merger Agreement with Adaptive Phage Therapeutics and Concurrent $50 Million Financing
BiomX Inc. today announced that it has entered into a definitive merger agreement with Adaptive Phage Therapeutics, Inc. (“APT”), a U.S.-based privately-held, clinical-stage biotechnology company pioneering the development of phage-based therapies to combat bacterial infections (the “Acquisition”).
March 6, 2024
·
15 min read
Press Releases
PHAXIAM Presented its IVD Phagogram test and updated phage susceptibility tracking at the first “Phagogram Day”
November 18, 2024
·
5 min read
Deals
BiomX Announces Closing of the Acquisition of Adaptive Phage Therapeutics and Concurrent $50 Million Financing
BiomX Inc. announced the closing of its previously announced acquisition of Adaptive Phage Therapeutics, Inc. and its previously announced $50 million private placement to certain institutional accredited investors, which was led by affiliates of Deerfield Management Company and the AMR Action Fund, and additional investors including the Cystic Fibrosis Foundation, OrbiMed and Nantahala Capital.
March 18, 2024
·
11 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Genetown
PHAXIAM Therapeutics announces high coverage performance of its two anti-Staphylococcus aureus phages over clinical strains
PHAXIAM Therapeutics (Nasdaq & Euronext: PHXM), today announced a very high spectrum of activity of its anti-S. aureus (PP1493 and PP1815) phages against clinical bacterial strains.
October 9, 2023
·
5 min read
Biotech Beach
Armata Pharmaceuticals Announces Presentation at Phage Futures: Global Digital Summit 2023
Armata Pharmaceuticals, Inc. today announced that its Chief Medical Officer, Mina Pastagia , M.D., MS, will deliver a presentation at Phage Futures: Global Digital Summit 2023, which is being held virtually on October 25th.
October 19, 2023
·
1 min read
BioCapital
Adaptive Phage Therapeutics Announces First Patient Dosed in the PHAGE Clinical Trial Evaluating Phage Therapy in Cystic Fibrosis-related Respiratory Infection
Adaptive Phage Therapeutics, Inc., today announced the first patient has been dosed in the PHAGE clinical trial, evaluating bacteriophage therapy in adults with cystic fibrosis (CF) who carry Pseudomonas aeruginosa ( P. aeruginosa ) in their lungs.
January 12, 2023
·
5 min read
Business
Adaptive Phage Therapeutics Enters Collaboration and License Agreement with Hebrew University of Jerusalem and Hadassah Medical Center
Adaptive Phage Therapeutics is pleased to announce a collaboration and license agreement with the Israeli Phage Therapy Center (IPTC) of the Hebrew University of Jerusalem and Hadassah Medical Center.
May 24, 2023
·
7 min read
Lone Star Bio
Nanoscope Therapeutics to Present at the BIO International Convention - May 29, 2024
Nanoscope Therapeutics Inc today announced that management will present at the BIO International Convention, taking place June 3-6, 2024, in San Diego, California.
May 29, 2024
·
1 min read
Pharm Country
Azitra, Inc. Announces Presentation at the 2024 BIO International Convention
Azitra, Inc. today announced that management will present at the 2024 BIO International Convention being held June 3-6, 2024 in San Diego, California.
May 31, 2024
·
4 min read
1 of 71,302
Next